ProNAi Therapeutics (NASDAQ:DNAI)

ProNAi Therapeutics (NASDAQ:DNAI)


Share Price
0
Change
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

ProNAi Therapeutics

ProNAi Therapeutics, Inc. is a clinical-stage oncology company. The Company develops and commercializes a portfolio of therapeutics based on its deoxyribonucleic acid interference (DNAi) technology platform for patients with cancer and hematological diseases.

EPIC: DNAI
Market: NASDAQ:DNAI
Sector: Pharma & Biotech
Website: pronai.com
col 3
col 4
col 5
col 6

ProNAi Therapeutics Timeline

Columns Including DNAI

VIEW ALL

Market Reports Including DNAI

VIEW ALL

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use